CS
HALO icon

Credit Suisse’s Halozyme HALO Stock Holding History

Credit Suisse’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-21,200
Closed -$479K – 4356
2015
Q2 		$479K Buy
+21,200
New +$373K ﹤0.01% 3758

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Credit Suisse's HALO Position: Q1 2024 in Review

Credit Suisse reduced its Halozyme (HALO) stake by 1% in Q1 2024, selling an estimated $79.9K and leaving 201,642 shares worth $8.2M. The position accounts for 0.01% of the portfolio, ranked #1021.

Credit Suisse first reported a position in HALO in Q2 2013 and has held it in 44 quarters since. The position peaked at $14.7M in Q2 2015. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

  • Credit Suisse held 201,642 shares of Halozyme worth $8.2M as of Q1 2024.
  • Credit Suisse sold 2,131 Halozyme shares in Q1 2024, an estimated $79.9K.
  • Halozyme made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1021 holding.
  • Credit Suisse first reported a position in Halozyme in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Halozyme position peaked at $14.7M in Q2 2015.
  • 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.